A Backgrounder: The 340B Drug Program in 2024
The 340B Drug Pricing Program was enacted by Congress in 1992 and has become the second largest federally sponsored drug program in the U.S. only surpassed by Medicare Part D.
The 340B Drug Pricing Program was enacted by Congress in 1992 and has become the second largest federally sponsored drug program in the U.S. only surpassed by Medicare Part D.
In 2021, Jessica Sheth Bhutada, MD, MS, and colleagues uncovered a startling 2% annual uptick in metastatic stomach cancer in young adults, despite declining rates in older adults. Three years later, they are still trying to understand why.
Oral cannabis extract could be an effective adjunct to standard antiemetic prophylaxis for patients with chemotherapy-induced nausea and vomiting (CINV), according to the results of a first-of-its-kind phase 2/3 study published in the Journal of Clinical Oncology.
For patients with kidney cancer, understanding how palliative care can help is essential throughout the treatment process.
The fight against pharmacy benefit managers is ramping up, not only at the state level in Arkansas but also on Capitol Hill.
Following a lung cancer diagnosis, many patients wonder what the next steps are — from treatment options, next-generation sequencing, surveillance and more.
A new study released to coincide with World Cancer Research Day today argues that wider access to clinical trials of new cancer treatments is one of the best ways to save lives from the disease.
These are some facts from the National Institute of Mental Health about depression and cancer.
Rebecca Smith, a breast cancer survivor, didn’t think much about it in 2018 when Novant Health bought Lake Norman Oncology, the practice in Mooresville where she had regular checkups with her cancer doctor.
A cancer journey brings with it plenty of questions for patients, caregivers and survivors.